Ocular Therapeutix, Inc. (OCUL)
10.70
-0.34
(-3.08%)
USD |
NASDAQ |
Mar 05, 12:03
Ocular Therapeutix Cash from Investing (Quarterly) : -2.839M for Dec. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Regeneron Pharmaceuticals, Inc. | 220.30M |
| Abbott Laboratories | -913.00M |
| EyePoint Plc | -- |
| Quince Therapeutics, Inc. | -1.781M |
| Ernexa Therapeutics, Inc. | -0.022M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -54.25M |
| Cash from Financing (Quarterly) | 449.38M |
| Free Cash Flow | -216.89M |
| Free Cash Flow Per Share (Quarterly) | -0.2561 |
| Free Cash Flow to Equity (Quarterly) | -57.05M |
| Free Cash Flow to Firm (Quarterly) | -54.26M |
| Free Cash Flow Yield | -10.83% |